(Q37773298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Carbohydrate targets in HIV vaccine research: lessons from failures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

4

Thomas Kieber-Emmons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Swetha Garimalla

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Behjatolah Monzavi-Karbassi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

777-794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636023%20AND%20SRC:MED&resulttype=core&format=json

A brief history of HIV vaccine research: stepping back to the drawing board?

7 February 2020

cites work

1 reference

A review of vaccine research and development: meningococcal disease

21 January 2018

1 reference

Vaccine development against HIV-1: current perspectives and future directions.

21 January 2018

1 reference

HIV vaccine development: lessons from the past and promise for the future

21 January 2018

1 reference

HIV/AIDS vaccines: a need for new concepts?

21 January 2018

1 reference

An HIV vaccine--challenges and prospects

21 January 2018

1 reference

HIV vaccine efficacy trials: towards the future of HIV prevention

21 January 2018

1 reference

Failure of the Merck HIV vaccine: an uncertain step forward.

21 January 2018

1 reference

Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.

21 January 2018

1 reference

Immunity, immunopathology and vaccines against HIV?

21 January 2018

1 reference

Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'.

21 January 2018

1 reference

What is missing in immunology to understand immunity?

21 January 2018

1 reference

Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency

21 January 2018

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection

21 January 2018

1 reference

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells

21 January 2018

1 reference

Enhancing antibodies in HIV infection

21 January 2018

1 reference

Challenges in the development of an HIV-1 vaccine

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma

21 January 2018

1 reference

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point

21 January 2018

1 reference

Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120

21 January 2018

1 reference

Genetic drift and within-host metapopulation dynamics of HIV-1 infection

21 January 2018

1 reference

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

21 January 2018

1 reference

Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors

21 January 2018

1 reference

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

21 January 2018

1 reference

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

21 January 2018

1 reference

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.

21 January 2018

1 reference

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

21 January 2018

1 reference

HIV-specific CD8+ T cells: serial killers condemned to die?

21 January 2018

1 reference

Responses of CD8(+) T cells to intracellular bacteria

21 January 2018

1 reference

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

On natural and artificial vaccinations

21 January 2018

1 reference

Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus

21 January 2018

1 reference

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

21 January 2018

1 reference

How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?

21 January 2018

1 reference

Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques

21 January 2018

1 reference

Therapeutic vaccination against chronic viral infections

21 January 2018

1 reference

HIV immunopathogenesis and strategies for intervention.

21 January 2018

1 reference

B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection

21 January 2018

1 reference

The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens

21 January 2018

1 reference

The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells

21 January 2018

1 reference

Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

21 January 2018

1 reference

Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion

21 January 2018

1 reference

Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae

21 January 2018

1 reference

Vaccines against polysaccharide antigens

21 January 2018

1 reference

Natural antibodies and complement link innate and acquired immunity

21 January 2018

1 reference

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

21 January 2018

1 reference

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

21 January 2018

1 reference

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens

21 January 2018

1 reference

Role of natural and immune IgM antibodies in immune responses

21 January 2018

1 reference

Presence of IgM antibodies which sensitize HIV-1-infected cells to cytolysis by homologous complement in long-term survivors of HIV infection

21 January 2018

1 reference

Fucosylated lactosamines participate in adhesion of HIV-1 envelope glycoprotein to dendritic cells

21 January 2018

1 reference

Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens

21 January 2018

1 reference

Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.

21 January 2018

1 reference

Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni

21 January 2018

1 reference

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

21 January 2018

1 reference

High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.

21 January 2018

1 reference

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

21 January 2018

1 reference

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

21 January 2018

1 reference

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

21 January 2018

1 reference

Immunostimulating complexes (ISCOMs) for nasal vaccination

21 January 2018

1 reference

Mucosal HIV vaccines: where are we now?

21 January 2018

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum

21 January 2018

1 reference

Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein

21 January 2018

1 reference

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins

21 January 2018

1 reference

Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system

21 January 2018

1 reference

Role of B-1a cells in autoimmunity

21 January 2018

1 reference

Autoimmunity, microbial immunity and the immunological homunculus

21 January 2018

1 reference

21 January 2018

AIDS and glycosylation

1 reference

Functions of HIV envelope glycans

21 January 2018

1 reference

Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells

21 January 2018

1 reference

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

21 January 2018

1 reference

Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein

21 January 2018

1 reference

Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

21 January 2018

1 reference

Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response

21 January 2018

1 reference

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

21 January 2018

1 reference

Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions

21 January 2018

1 reference

DC-SIGN: escape mechanism for pathogens

21 January 2018

1 reference

HIV gp120 receptors on human dendritic cells.

21 January 2018

1 reference

Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.

21 January 2018

1 reference

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

21 January 2018

1 reference

Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3.

21 January 2018

1 reference

Demonstration of peripheral fucose units in N-linked glycans of human immunodeficiency virus type 1 gp 120: effects on glycoprotein conformation

21 January 2018

1 reference

Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates

21 January 2018

1 reference

Host-cell-specific glycosylation of HIV-2 envelope glycoprotein

21 January 2018

1 reference

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

21 January 2018

1 reference

The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells

21 January 2018

1 reference

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

21 January 2018

1 reference

DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes

21 January 2018

1 reference

HIV-1 envelope evolution and vaccine efficacy

21 January 2018

1 reference

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

21 January 2018

1 reference

Lectin—Carbohydrate Interactions and Infectivity of Human Immunodeficiency Virus Type 1 (HIV-1)

21 January 2018

1 reference

A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus

21 January 2018

1 reference

Lectin-mediated effects on HIV type 1 infection in vitro.

21 January 2018

1 reference

Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis

21 January 2018

1 reference

The C-type lectin superfamily in the immune system

21 January 2018

1 reference

Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.

21 January 2018

1 reference

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

21 January 2018

1 reference

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope

21 January 2018

1 reference

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

21 January 2018

1 reference

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

21 January 2018

1 reference

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

21 January 2018

1 reference

Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide

21 January 2018

1 reference

Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides

21 January 2018

1 reference

Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency

21 January 2018

1 reference

Structural basis of trimannoside recognition by concanavalin A

21 January 2018

1 reference

Thermodynamics of lectin-carbohydrate interactions. Titration microcalorimetry measurements of the binding of N-linked carbohydrates and ovalbumin to concanavalin A.

21 January 2018

1 reference

A comparison of the fine saccharide-binding specificity of Dioclea grandiflora lectin and concanavalin A.

21 January 2018

1 reference

Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding

21 January 2018

1 reference

Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.

21 January 2018

1 reference

A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120

21 January 2018

1 reference

Targeting carbohydrate antigens in HIV vaccine development

21 January 2018

1 reference

Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus

21 January 2018

1 reference

Directing the immune response to carbohydrate antigens

21 January 2018

1 reference

Priming characteristics of peptide mimotopes of carbohydrate antigens

21 January 2018

1 reference

Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity.

21 January 2018

1 reference

Defining carbohydrate antigens as HIV vaccine candidates

21 January 2018

1 reference

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation

21 January 2018

1 reference

Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

21 January 2018

1 reference

Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells

21 January 2018

1 reference

Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

21 January 2018

1 reference

Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease

21 January 2018

1 reference

Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells

21 January 2018

1 reference

The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways

21 January 2018

1 reference

Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission

21 January 2018

1 reference

Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner

21 January 2018

1 reference

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

21 January 2018

1 reference

Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens.

21 January 2018

1 reference

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

21 January 2018

1 reference

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

Neutralization of animal virus infectivity by antibody

21 January 2018

1 reference

Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes

21 January 2018

1 reference

The role of antibody concentration and avidity in antiviral protection.

21 January 2018

1 reference

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

21 January 2018

1 reference

The antiviral activity of antibodies in vitro and in vivo.

21 January 2018

1 reference

In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers

21 January 2018

1 reference

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

21 January 2018

1 reference

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells

21 January 2018

1 reference

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

21 January 2018

1 reference

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

21 January 2018

1 reference

Why do we not yet have a human immunodeficiency virus vaccine?

21 January 2018

1 reference

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

21 January 2018

1 reference

Therapeutic vaccination for future management of HIV/AIDS.

21 January 2018

1 reference

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

21 January 2018

1 reference

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements

21 January 2018

1 reference

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

21 January 2018

1 reference

Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection

21 January 2018

1 reference

Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo

21 January 2018

1 reference

Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures

21 January 2018

1 reference

Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys

21 January 2018

1 reference

Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence

21 January 2018

1 reference

HIV-1 immunopathogenesis: how good interferon turns bad.

21 January 2018

1 reference

Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication

21 January 2018

1 reference

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group

21 January 2018

1 reference

CCR5 as target for HIV-1 gene therapy

21 January 2018

1 reference

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection

21 January 2018

1 reference

Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.

21 January 2018

1 reference

Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120.

21 January 2018

1 reference

Personalized therapeutics: HIV treatment in adolescents

21 January 2018

1 reference

T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover

21 January 2018

1 reference

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

Specificity of DC-SIGN for mannose- and fucose-containing glycans

21 January 2018

1 reference

Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120

21 January 2018

1 reference